The treatment-associated variations of PlGF concentrations (ΔPlGF) were overall highly significant protecting factors against the development of PMCs whereas variations of sFlt1 (ΔsFlt1) were highly significant risk factors for PMCs.
← all excerpts
Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.
1
—
—